syk
-
Biologics
Orthovita shareholders sue to stop $316 million Stryker buyout
Shareholders of Orthovita Inc. (NSDQ: VITA), a Malvern, Pa.-based orthopedic biologics maker, are suing over a proposed $316 million merger by…
Read More » -
Recon
Michael P. Mogul Appointed New CEO of DJO
SAN DIEGO–(BUSINESS WIRE)– DJO Global, Inc. (“DJO” or the “Company”), a leading provider of medical device solutions for musculoskeletal health,…
Read More » -
Stryker Launches Tender Offer
Orthopedic devices giant Stryker Corp (SYK – Analyst Report) has commenced its $3.85 per share tender offer for its previously announced acquisition…
Read More » -
Stryker Receives FDA 510(K) Clearance for Shapematch® Cutting Guides
Kalamazoo, Michigan – May 24, 2011 – Stryker Orthopaedics, a division of Stryker Corporation (NYSE:SYK), today announced that its ShapeMatch…
Read More » -
High Above Average Volume On Stryker
New York, May 16th (TradersHuddle.com) – Unusual high volume detected on shares of Stryker Corporation (NYSE:SYK), early in the trading…
Read More » -
Biologics
Stryker Announces Definitive Agreement to Acquire Orthovita, Inc. for $3.85 Per Share in Cash
Kalamazoo, Michigan – May 16, 2011- Stryker Corporation (NYSE:SYK) announced today a definitive agreement to acquire Orthovita, Inc. (Nasdaq:VITA), a…
Read More » -
Stryker Announces Kevin Lobo to Head New Neurotechnology and Spine Group
Kalamazoo, Michigan – April 27, 2011 – Stryker Corporation (NYSE: SYK) today announced that former Johnson & Johnson executive Kevin…
Read More » -
Trading Idea – Stryker Broke Support, What To Expect?
New York, April 13th (TradersHuddle.com) – Shares of Stryker Corporation (NYSE:SYK) closed the trading session at $59.84 below calculated support at…
Read More » -
Recon
Stryker CEO MacMillan: No raise, please
Stryker Corp. (NYSE: SYK ) CEO Stephen MacMillan once again deferred a pay raise in 2010 due to the “challenging business…
Read More » -
Stryker Biotech, execs blast back at feds
Former Stryker Biotech CEO Mark Philip, the company and three other executives fire back at federal prosecutors, arguing for the…
Read More » -
Goldman Neutral On Stryker (SYK)
Goldman Sachs has a Neutral rating on Stryker Corp. (NYSE: SYK) after the company announced a sale of a division. In a note…
Read More » -
Deutsche Bank Maintains Hold Rating of Stryker and Zimmer
As the market becomes highly focused on monthly trends in an effort to understand whether things are getting better or…
Read More » -
ETEX Corporation Announces Distribution Agreement With Stryker
CAMBRIDGE, Mass., July 14 /PRNewswire/ — ETEX Corporation, an advanced biomaterials company, announced today that it has entered into a non-exclusive distribution…
Read More »